Search clinical trials for: eltrombopag combining rituximab
Total 3338 results
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
European Society for Blood and Marrow TransplantationEnrolling by invitationSevere Aplastic AnemiaFrance
-
M.D. Anderson Cancer CenterGlaxoSmithKlineTerminated
-
Peking University People's HospitalQilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaboratorsNot yet recruitingZanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaImmune ThrombocytopeniaChina
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRefractory Lymphoma | DLBCL | MYD88 Gene Mutation | Relapse | CD79A Gene Mutation | CD79B Gene Mutation
-
The Lymphoma Academic Research OrganisationRoche Pharma AGCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedMicroscopic Polyangiitis | Granulomatosis With Polyangiitis | Renal Limited FormsFrance
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
Westside Medical Associates of Los AngelesGilead SciencesUnknownHeart Disease | AnginaUnited States
-
mAbxience Research S.L.Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA; Innogene Kalbiotech Pte... and other collaboratorsCompletedDiffuse Large B-cell LymphomaMalaysia, Argentina, Colombia, India, South Africa, Philippines, Brazil, Russian Federation, Indonesia, Iran, Islamic Republic of, Mexico, Paraguay
-
Kuopio University HospitalCompletedRheumatoid ArthritisFinland
-
AmgenCompletedArthritis, RheumatoidUnited States, Germany, Bulgaria, Hungary, Poland, Estonia
-
Narendranath EpperlaEli Lilly and CompanyNot yet recruitingMarginal Zone LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
GlaxoSmithKlineCompletedHepatitis CUnited States
-
Peking University People's HospitalBeijing Friendship Hospital; Beijing Tongren Hospital; Beijing Hospital; Navy General...Not yet recruitingPurpura, Thrombocytopenic, IdiopathicChina
-
Central Hospital, Nancy, FranceEli Lilly and CompanyNot yet recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisFrance
-
University of PennsylvaniaWashington University School of Medicine; Yale University; University of Maryland and other collaboratorsCompleted
-
National Cancer Institute (NCI)RecruitingWaldenstrom Macroglobulinemia | Lymphoplasmacytic LymphomaUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsCompletedHypertension With Renal DysfunctionJapan
-
University of WashingtonMillennium Pharmaceuticals, Inc.Active, not recruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Small Lymphocytic Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal...United States
-
Roswell Park Cancer InstituteGlaxoSmithKlineTerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital HeidelbergUnknownCD20+ Aggressive Lymphoma, Mantle Cell LymphomaGermany
-
University of Wisconsin, MadisonGenentech, Inc.WithdrawnEnd Stage Renal DiseaseUnited States
-
PETHEMA FoundationCompletedAcute Lymphoblastic Leukemia | Burkitt's LymphomaSpain
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
University of Alabama at BirminghamCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Charite University, Berlin, GermanyHoffmann-La RocheUnknownAnkylosing SpondylitisGermany
-
SandozHexal AGCompletedRheumatoid ArthritisUnited States, Germany, Poland, Hungary
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Dong-A University HospitalCompleted
-
University of California, San FranciscoCompletedLymphoma | Brain and Central Nervous System Tumors
-
Assistance Publique - Hôpitaux de ParisCompletedThrombotic Thrombocytopenic PurpuraFrance
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States